Physician-supervised weight loss

From W8MD weight loss and sleep centers

Physician-supervised weight loss using evidence-based obesity medicine, GLP-1 injections, diet pills, sleep medicine, nutrition, and W8MD maintenance support

Physician-supervised weight loss
[[File:Before-and-after-weight-loss.jpeg|220px|alt=Physician-supervised weight loss]]
Physician-supervised weight loss combines medical evaluation, evidence-based treatment, nutrition, activity, and long-term maintenance
Specialty Obesity medicine, endocrinology, nutrition, sleep medicine, preventive medicine
Uses Obesity, overweight, insulin resistance, prediabetes, type 2 diabetes, metabolic syndrome, sleep apnea, hypertension






Related W8MD Weight Loss, Sleep and MedSpa, GLP-1 weight loss, semaglutide, tirzepatide, phentermine, weight loss maintenance
W8MD Weight Loss, Sleep and MedSpa offers evidence-based medical weight loss, sleep medicine, nutrition, and MedSpa care.
A physician-supervised program can combine nutrition, anti-obesity medication, GLP-1 weight loss injections, and follow-up care.
W8MD helps eligible patients with traditional diet pills and newer GLP-1 weight loss options when medically appropriate.
Meal replacements may help selected patients with structure, protein intake, portion control, and affordability.
W8MD has helped thousands of patients lose weight and maintain long-term results.
File:Sleep-apnea.png
Sleep apnea is a common obesity-related condition that can make weight loss harder if untreated.

Physician-supervised weight loss is an evidence-based medical approach to weight loss in which a licensed physician, obesity medicine physician, bariatrician, or trained medical provider evaluates, treats, and monitors patients with obesity, overweight, insulin resistance, prediabetes, type 2 diabetes, metabolic syndrome, sleep apnea, hypertension, fatty liver disease, and related conditions. Unlike commercial diet programs, physician-supervised weight loss treats excess weight as a chronic medical condition that may require long-term care, medication, nutrition support, sleep evaluation, behavioral strategies, and maintenance planning.

W8MD Weight Loss, Sleep and MedSpa is a physician-supervised weight loss program with over 15 years of experience helping patients lose weight and keep it off. Since 2011, W8MD has helped thousands of satisfied patients through individualized medical weight loss, nutrition, meal replacements, anti-obesity medication, GLP-1 weight loss injections, sleep medicine, sleep apnea testing, and ongoing weight loss maintenance programs.

W8MD serves patients through locations in New York City and Philadelphia, with service areas including Greater New York City, Brooklyn, Queens, Manhattan, Staten Island, Long Island, Connecticut, New Jersey, Philadelphia, Greater Philadelphia, Delaware, and surrounding communities.

Overview

Physician-supervised weight loss is designed for patients who need more than a simple diet plan. Many people struggle with weight because of hunger, cravings, insulin resistance, sleep apnea, hormonal changes, medications, stress, poor sleep, metabolic adaptation, or repeated weight regain after dieting.

A physician-supervised program may include:

Why physician supervision matters

Weight loss can affect blood pressure, blood sugar, medications, hydration, nutrition, muscle mass, gallbladder risk, sleep, and mood. Medical supervision helps patients lose weight safely while monitoring for side effects and complications.

Physician supervision is especially important for patients with:

The National Institute of Diabetes and Digestive and Kidney Diseases states that prescription weight-management medications may be used as an adjunct to lifestyle changes for selected adults with obesity or overweight and weight-related health problems.Prescription Medications to Treat Overweight and Obesity(link). National Institute of Diabetes and Digestive and Kidney Diseases.

W8MD physician weight loss program

W8MD Weight Loss, Sleep and MedSpa offers a comprehensive physician-supervised weight loss program that combines medical treatment with practical lifestyle support. The program is individualized because no single diet, medication, or plan works for every patient.

W8MD’s physician weight loss program may include:

Over 15 years of experience

W8MD has been helping patients since 2011, giving the program over 15 years of experience in physician-supervised weight loss, obesity medicine, nutrition support, and maintenance planning. This experience matters because long-term weight control requires more than starting a diet. It requires identifying why weight gain happened, choosing the right treatment, adjusting the plan over time, preventing relapse, and treating obesity as a chronic medical condition.

Evidence-based medicine

Physician-supervised weight loss uses evidence-based strategies rather than fad diets or quick fixes. These strategies may include nutrition therapy, structured meal plans, anti-obesity medications, GLP-1 therapy, sleep apnea treatment, physical activity, behavioral strategies, and long-term follow-up.

The Obesity Medicine Association describes obesity treatment as a comprehensive approach built around nutrition, physical activity, behavior modification, and medical interventions.The Four Pillars of Obesity Treatment(link). Obesity Medicine Association.

Traditional diet pills

Traditional prescription weight loss medications can be helpful for selected patients when used with medical supervision. These medications may reduce appetite, improve portion control, or help patients adhere to a reduced-calorie plan.

Phentermine

Phentermine is a sympathomimetic appetite suppressant used as a short-term adjunct to calorie restriction, exercise, and behavioral modification for patients with obesity or overweight with risk factors.Phentermine hydrochloride capsule prescribing information(link). DailyMed, National Library of Medicine.

Phentermine may not be appropriate for patients with certain conditions such as uncontrolled hypertension, cardiovascular disease, hyperthyroidism, glaucoma, pregnancy, or a history of drug abuse.Phentermine hydrochloride capsule contraindications(link). DailyMed, National Library of Medicine.

Phentermine/topiramate

Phentermine/topiramate, sold under the brand name Qsymia, combines the appetite-suppressing effect of phentermine with topiramate. It is one of the FDA-approved medications for chronic weight management in selected patients.Prescription Medications to Treat Overweight and Obesity(link). National Institute of Diabetes and Digestive and Kidney Diseases.

Diethylpropion

Diethylpropion is a sympathomimetic anorectic medication historically used for short-term weight management in selected patients. It should be used only with medical supervision because it can affect blood pressure, heart rate, sleep, anxiety, and medication interactions.

Phendimetrazine

Phendimetrazine is a sympathomimetic amine used as an anorectic medication in selected patients with obesity. DailyMed describes phendimetrazine as a phenylalkylamine sympathomimetic amine in a class of drugs commonly known as anorectics or anorexigenics.Phendimetrazine tartrate capsule prescribing information(link). DailyMed, National Library of Medicine.

Contrave

Contrave is the brand name for naltrexone/bupropion, a chronic weight-management medication that works through appetite and reward pathways. It may be useful for selected patients with cravings or emotional eating patterns, but it is not appropriate for everyone.

Wegovy

Wegovy is the brand name for semaglutide used for chronic weight management and selected cardiovascular risk-reduction indications. The FDA approved Wegovy to reduce the risk of major adverse cardiovascular events in adults with established cardiovascular disease and either obesity or overweight.FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight(link). U.S. Food and Drug Administration.March 8, 2024.

Foundayo

Foundayo is the brand name for orforglipron, an oral GLP-1 receptor agonist for weight management. Lilly announced FDA approval of Foundayo in April 2026 as an oral GLP-1 pill for weight loss.FDA approves Lilly's Foundayo orforglipron(link). Eli Lilly and Company.April 1, 2026.

As with all obesity medications, Foundayo should be used only after medical evaluation and when medically appropriate.

GLP-1 weight loss injections

GLP-1 weight loss injections and related incretin-based medications have transformed modern obesity medicine. These medications may reduce appetite, improve satiety, reduce food noise, improve blood sugar control, and help selected patients achieve significant weight loss.

W8MD may evaluate eligible patients for:

Semaglutide

Semaglutide is a GLP-1 receptor agonist used in products such as Wegovy, Ozempic, and Rybelsus. Wegovy is used for chronic weight management, while Ozempic and Rybelsus are primarily diabetes brands.

Tirzepatide

Tirzepatide is a dual GIP and GLP-1 receptor agonist used in Mounjaro and Zepbound. The FDA approved Zepbound for chronic weight management in adults with obesity or overweight with at least one weight-related condition.FDA Approves New Medication for Chronic Weight Management(link). U.S. Food and Drug Administration.November 8, 2023.

The FDA also approved Zepbound as the first medication for moderate-to-severe obstructive sleep apnea in adults with obesity.FDA Approves First Medication for Obstructive Sleep Apnea(link). U.S. Food and Drug Administration.December 20, 2024.

Affordable W8MD weight loss solutions

Affordable physician-supervised weight loss and GLP-1 options

W8MD Weight Loss, Sleep and MedSpa offers affordable physician-supervised medical weight loss programs for eligible patients.

  • Affordable GLP-1 options starting at $29.99/week and up with insurance for visits for eligible patients.
  • Most insurances accepted for qualifying medical visits.
  • Self-pay GLP-1 injection options starting from $59.99/week and up when available and medically appropriate.
  • Traditional medication options such as phentermine, phentermine/topiramate, diethylpropion, phendimetrazine, and Contrave may be considered when appropriate.
  • Pricing, medication access, insurance coverage, prior authorization, and eligibility vary by patient, medication, pharmacy availability, location, and medical evaluation.

Insurance acceptance

W8MD accepts most insurances for qualifying physician-supervised visits, testing, counseling, and related medical evaluation when coverage is available. Insurance coverage varies by plan, diagnosis, medication, employer benefits, deductible, copay, and prior authorization requirements.

W8MD may help patients with:

  • Medical visit coverage
  • Weight-loss evaluation
  • Sleep evaluation
  • Laboratory testing when covered
  • Prior authorization support when available
  • GLP-1 eligibility review
  • Documentation of weight-related medical conditions
  • Maintenance follow-up

W8MD success stories

W8MD has helped thousands of satisfied patients lose weight and maintain their results. Patient outcomes vary, but many patients report improvements in hunger, cravings, energy, blood pressure, blood sugar, cholesterol, mobility, confidence, and quality of life.

Highlighted W8MD success story

FANTASTIC program! Truly a life changer!

“FANTASTIC program! Truly a life changer! The first several months I lost on average 3 pounds a week. I have now lost 87 pounds in 10 months and I'm still losing! I can say it feels almost effortless, for with the elimination of most carbs plus the medication I have ZERO cravings and minimal hunger. My cholesterol, blood pressure, and blood sugar have all returned to normal having previously been considerably elevated. I look and feel twenty years younger (I am 57.) Staff is friendly and supportive, and the science works. I did not think that I would be able to achieve such results, and certainly not in less than a year. I am amazed at my success, and I could not have done it without Dr. Tumpati and W8MD.”

- D.M., actual W8MD patient who lost 100 lbs and has maintained the weight loss for over 10 years.

What makes W8MD different?

W8MD is different from many commercial diet programs because it combines medical expertise, obesity medicine, medications when appropriate, nutrition structure, sleep medicine, and long-term maintenance.

W8MD focuses on:

  • Treating obesity as a chronic medical condition
  • Reducing hunger and cravings
  • Improving metabolic health
  • Preserving lean body mass
  • Addressing insulin resistance
  • Screening for sleep apnea
  • Using evidence-based medications
  • Supporting affordable care
  • Accepting most insurances
  • Helping patients keep weight off

Medical conditions improved by weight loss

Physician-supervised weight loss may help improve or reduce risk factors for:

Sleep medicine and weight loss

W8MD includes sleep medicine because untreated sleep apnea can make weight loss harder. Sleep apnea can increase fatigue, cravings, blood pressure, insulin resistance, and daytime sleepiness.

W8MD may help with:

Nutrition and meal replacements

W8MD may use nutrition planning and meal replacements to help patients improve protein intake, reduce calories, reduce refined carbohydrates, and control portions.

Nutrition strategies may include:

Weight loss maintenance

A major goal of physician-supervised weight loss is not just losing weight but keeping it off. W8MD helps patients build a maintenance plan after initial weight loss.

Maintenance may include:

  • Ongoing medical follow-up
  • GLP-1 maintenance therapy
  • Lowest effective dose planning
  • Traditional medication adjustment
  • Protein-first eating
  • Strength training
  • Sleep apnea treatment
  • Weekly weight monitoring
  • Meal replacements when appropriate
  • Relapse prevention
  • Early treatment of weight regain

W8MD locations

W8MD serves patients from New York City and Philadelphia offices, with service areas extending throughout the region.

Location Address Phone Services Map
Brooklyn / New York City Weight Loss Center 2632 E 21st Street, Suite L3, Brooklyn, NY 11235 (718) 946-5500 Medical weight loss, GLP-1 weight loss injections, sleep medicine, MedSpa, nutrition View map
Philadelphia / Greater Philadelphia Weight Loss Center 1718 Welsh Road, 2nd Floor, Suite C, Philadelphia, PA 19115 (215) 676-2334 Medical weight loss, GLP-1 weight loss injections, sleep medicine, nutrition, wellness services View map

Service areas

Who may benefit?

Physician-supervised weight loss may be appropriate for patients who have:

  • BMI of 30 or higher
  • BMI of 27 or higher with medical problems
  • Repeated weight regain
  • Difficulty controlling hunger
  • Strong cravings
  • Prediabetes
  • Type 2 diabetes
  • High blood pressure
  • High cholesterol
  • Fatty liver disease
  • PCOS
  • Sleep apnea symptoms
  • Prior failed diet attempts
  • Interest in GLP-1 medication evaluation
  • Need for affordable weight-loss care

Safety and monitoring

Physician-supervised programs monitor safety and adjust treatment as needed. This is important because weight-loss medications can have side effects and may not be appropriate for everyone.

Monitoring may include:

  • Blood pressure
  • Weight trend
  • Appetite
  • Side effects
  • Hydration
  • Constipation
  • Blood sugar when appropriate
  • Medication interactions
  • Sleep symptoms
  • Nutritional intake
  • Protein intake
  • Weight maintenance risk

Frequently asked questions

What is physician-supervised weight loss?

Physician-supervised weight loss is a medical weight-loss program in which a physician or trained medical provider evaluates the patient, recommends evidence-based treatment, monitors safety, and supports long-term weight maintenance.

Does W8MD offer GLP-1 injections?

Yes. W8MD can evaluate eligible patients for GLP-1 weight loss injections such as semaglutide, Wegovy, Ozempic, tirzepatide, Mounjaro, and Zepbound when medically appropriate.

Does W8MD offer traditional diet pills?

Yes. W8MD may evaluate selected patients for traditional medications such as phentermine, phentermine/topiramate, diethylpropion, phendimetrazine, and Contrave when medically appropriate.

Does W8MD accept insurance?

Yes. W8MD accepts most insurances for qualifying medical visits and related services when coverage is available.

How much do W8MD GLP-1 options cost?

Affordable GLP-1 options may start at $29.99/week and up with insurance for visits for eligible patients. Self-pay GLP-1 injection options may start from $59.99/week and up when available and medically appropriate.

Can W8MD help patients keep weight off?

Yes. W8MD emphasizes long-term weight loss maintenance through follow-up visits, nutrition, protein planning, medication adjustment, sleep apnea care, and relapse prevention.

Can W8MD help with sleep apnea?

Yes. W8MD offers sleep medicine services and can screen for sleep apnea, arrange home sleep testing when appropriate, and help eligible adults with obesity and moderate-to-severe OSA evaluate Zepbound when appropriate.

Conclusion

Physician-supervised weight loss is a safer, more comprehensive, and more effective approach for many patients who struggle with obesity, insulin resistance, sleep apnea, and repeated weight regain. W8MD Weight Loss, Sleep and MedSpa offers over 15 years of experience, evidence-based medical weight loss, traditional diet pills, GLP-1 weight loss injections, meal replacements, sleep medicine, insurance-friendly care, affordable options, and long-term maintenance support. With locations in New York City and Philadelphia serving Greater New York City, Connecticut, New Jersey, Philadelphia, and Delaware, W8MD helps patients lose weight, improve health, and keep the weight off.

See also

Relevant WikiMD links

Further reading

  • Prescription Medications to Treat Overweight and Obesity(link). National Institute of Diabetes and Digestive and Kidney Diseases.
  • The Four Pillars of Obesity Treatment(link). Obesity Medicine Association.
  • FDA Approves New Medication for Chronic Weight Management(link). U.S. Food and Drug Administration.November 8, 2023.
  • FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight(link). U.S. Food and Drug Administration.March 8, 2024.
  • FDA Approves First Medication for Obstructive Sleep Apnea(link). U.S. Food and Drug Administration.December 20, 2024.
  • Phentermine hydrochloride capsule prescribing information(link). DailyMed, National Library of Medicine.
  • Phendimetrazine tartrate capsule prescribing information(link). DailyMed, National Library of Medicine.
  • FDA approves Lilly's Foundayo orforglipron(link). Eli Lilly and Company.April 1, 2026.

External links


Retrieved from "https://w8md.com/w/index.php?title=Physician-supervised_weight_loss&oldid=5923"